{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T21:49:40Z","timestamp":1775252980459,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jaip.2014.06.004","type":"journal-article","created":{"date-parts":[[2014,9,8]],"date-time":"2014-09-08T05:15:38Z","timestamp":1410153338000},"page":"601-606","source":"Crossref","is-referenced-by-count":49,"title":["Double-Blind Placebo-Controlled Trial of Dapsone in Antihistamine Refractory Chronic Idiopathic Urticaria"],"prefix":"10.1016","volume":"2","author":[{"given":"Matt","family":"Morgan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Cooke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverley","family":"Adams-Huet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2014.06.004_bib1","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1398-9995.2009.02179.x","article-title":"EAACI\/GA(2)LEN\/EDF\/WAO guideline: definition, classification and diagnosis of urticaria","volume":"64","author":"Zuberbier","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2014.06.004_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2133.1997.tb14895.x","article-title":"The impact of chronic urticaria on the quality of life","volume":"136","author":"O\u2019Donnell","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2014.06.004_bib3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2500\/aap.2008.29.3151","article-title":"Chronic urticaria: diagnosis and management","volume":"29","author":"Khan","year":"2008","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2014.06.004_bib4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2222.2007.02678.x","article-title":"BSACI guidelines for the management of chronic urticaria and angio-oedema","volume":"37","author":"Powell","year":"2007","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2014.06.004_bib5","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1067\/mai.2000.105706","article-title":"Chronic urticaria","volume":"105","author":"Greaves","year":"2000","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.06.004_bib6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2010.02496.x","article-title":"Unmet clinical needs in chronic spontaneous urticaria. A GA(2)LEN task force report","volume":"66","author":"Maurer","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2014.06.004_bib7","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1398-9995.2009.02178.x","article-title":"EAACI\/GA(2)LEN\/EDF\/WAO guideline: management of urticaria","volume":"64","author":"Zuberbier","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2014.06.004_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJMcp011186","article-title":"Clinical practice. Chronic urticaria and angioedema","volume":"346","author":"Kaplan","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2014.06.004_bib9","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/ACI.0b013e32835571f6","article-title":"Calcineurin inhibitors in chronic urticaria","volume":"12","author":"Trojan","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.06.004_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaci.2013.05.013","article-title":"Omalizumab in patients with symptomatic chronic idiopathic\/spontaneous urticaria despite standard combination therapy","volume":"132","author":"Kaplan","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2014.06.004_bib11","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1056\/NEJMoa1215372","article-title":"Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria","volume":"368","author":"Maurer","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2014.06.004_bib12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0006-2952(83)90568-3","article-title":"Inhibition of the release of prostaglandins, leukotrienes and lysosomal acid hydrolases from macrophages by selective inhibitors of lecithin biosynthesis","volume":"32","author":"Bonney","year":"1983","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jaip.2014.06.004_bib13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/0006-2952(92)90449-S","article-title":"Inhibition of the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase by dapsone","volume":"44","author":"Bozeman","year":"1992","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jaip.2014.06.004_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/1523-1747.ep12555654","article-title":"Dapsone suppresses integrin-mediated neutrophil adherence function","volume":"98","author":"Booth","year":"1992","journal-title":"J\u00a0Investig Dermatol"},{"key":"10.1016\/j.jaip.2014.06.004_bib15","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000211346","article-title":"Dapsone inhibits the generation of 5-lipoxygenase products in human polymorphonuclear leukocytes","volume":"8","author":"Wozel","year":"1995","journal-title":"Skin Pharmacol"},{"key":"10.1016\/j.jaip.2014.06.004_bib16","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archderm.1997.03890470111018","article-title":"Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases","volume":"133","author":"Chren","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2014.06.004_bib17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1067\/mjd.2001.114733","article-title":"Dapsone and sulfones in dermatology: overview and update","volume":"45","author":"Zhu","year":"2001","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2014.06.004_bib18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2340\/00015555-1268","article-title":"Hypersensitivity reactions to dapsone: a systematic review","volume":"92","author":"Lorenz","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2014.06.004_bib19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2133.1978.tb06188.x","article-title":"Urticaria-like lesions associated with systemic lupus erythematosus: response to dapsone","volume":"99","author":"Matthews","year":"1978","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2014.06.004_bib20","first-page":"254","article-title":"Low-dose dapsone in chronic idiopathic urticaria: preliminary results of an open study","volume":"85","author":"Cassano","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2014.06.004_bib21","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1468-3083.2007.02510.x","article-title":"Prospective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria","volume":"22","author":"Engin","year":"2008","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2014.06.004_bib22","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jaad.2004.02.013","article-title":"Management of autoimmune bullous diseases: pharmacology and therapeutics","volume":"51","author":"Mutasim","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2014.06.004_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1529-8019.2012.01496.x","article-title":"Antibiotics used in nonbacterial dermatologic conditions","volume":"25","author":"Gordon","year":"2012","journal-title":"Dermatol Ther"},{"issue":"1","key":"10.1016\/j.jaip.2014.06.004_bib24","first-page":"CD004056","article-title":"Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita","author":"Kirtschig","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jaip.2014.06.004_bib25","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1529-8019.2010.01323.x","article-title":"The management of mucous membrane pemphigoid and pemphigus","volume":"23","author":"Knudson","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaip.2014.06.004_bib26","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0738-081X(99)00121-2","article-title":"Subcorneal pustular dermatosis","volume":"18","author":"Reed","year":"2000","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaip.2014.06.004_bib27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1046\/j.1365-2133.2000.03604.x","article-title":"Subcorneal pustular dermatosis type of IgA pemphigus: demonstration of autoantibodies to desmocollin-1 and clinical review","volume":"143","author":"Yasuda","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2014.06.004_bib28","doi-asserted-by":"crossref","first-page":"e179","DOI":"10.1016\/j.jaad.2010.06.018","article-title":"Cutaneous lupus erythematosus: update of therapeutic options part I","volume":"65","author":"Kuhn","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2014.06.004_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4248\/IJOS10032","article-title":"Pyoderma gangrenosum with oral involvement: case report and review of the literature","volume":"2","author":"Paramkusam","year":"2010","journal-title":"Int J Oral Sci"},{"key":"10.1016\/j.jaip.2014.06.004_bib30","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1610-0387.2007.0328.x","article-title":"Pyoderma gangrenosum: clinical presentation and outcome in 18 cases and review of the literature","volume":"5","author":"Hasselmann","year":"2007","journal-title":"J\u00a0Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaip.2014.06.004_bib31","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/01.rhu.0000249894.03016.de","article-title":"Beh\u00e7et disease: recommendation for clinical management of mucocutaneous lesions","volume":"12","author":"Lin","year":"2006","journal-title":"J\u00a0Clin Rheumatol"},{"key":"10.1016\/j.jaip.2014.06.004_bib32","first-page":"171","article-title":"Effect of dapsone on haemoglobin concentration in patients with leprosy","volume":"62","author":"Byrd","year":"1991","journal-title":"Lepr Rev"},{"key":"10.1016\/j.jaip.2014.06.004_bib33","first-page":"776","article-title":"Rheumatoid arthritis: the effects of treatment with dapsone on hemoglobin","volume":"11","author":"Grindulis","year":"1984","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jaip.2014.06.004_bib34","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1345\/aph.1Q139","article-title":"Dapsone-induced methemoglobinemia: a primer for clinicians","volume":"45","author":"Barclay","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaip.2014.06.004_bib35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0300-483X(01)00360-2","article-title":"Dapsone-mediated agranulocytosis: risks, possible mechanisms and prevention","volume":"162","author":"Coleman","year":"2001","journal-title":"Toxicology"},{"key":"10.1016\/j.jaip.2014.06.004_bib36","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1001\/archderm.1990.01670310081011","article-title":"The incidence of agranulocytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988","volume":"126","author":"Hornsten","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2014.06.004_bib37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1745-6673-1-9","article-title":"The dapsone hypersensitivity syndrome revisited: a potentially fatal multisystem disorder with prominent hepatopulmonary manifestations","volume":"1","author":"Kosseifi","year":"2006","journal-title":"J\u00a0Occup Med Toxicol"},{"key":"10.1016\/j.jaip.2014.06.004_bib38","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.jaci.2014.02.036","article-title":"The diagnosis and management of acute and chronic urticaria: 2014 update","volume":"133","author":"Bernstein","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"}],"updated-by":[{"DOI":"10.1016\/j.jaip.2014.10.006","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000}}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219814002621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219814002621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T20:29:04Z","timestamp":1538252944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219814002621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S2213219814002621"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2014.06.004","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]}}}